Ushbu ishga iqtibos qilgan ishlar

2 ta ish

Ish: Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease

1. Sarlavhasiz

   Anatoly Enikeev, Sergey Student, В. А. Иващенко +70

   BoshqaProspects and Key Tendencies of Science in Contemporary World20220 iqtibos

   ABIABI:AkademIndex/openalex/2022.other.001209

2. Sarlavhasiz

   Anatoly Enikeev, Sergey Student, В. А. Иващенко +70

   BoshqaProspects and Key Tendencies of Science in Contemporary World20220 iqtibos

   ABIABI:AkademIndex/openalex/2022.other.001280